| Literature DB >> 31742863 |
Shufei Song1,2,3, Javier V Perez3, William Svitko3, M Daniel Ricketts1,4, Elliot Dean5, David Schultz5, Ronen Marmorstein1,4, F Brad Johnson1,3,6.
Abstract
Cell senescence is accompanied, and in part mediated, by changes in chromatin, including histone losses, but underlying mechanisms are not well understood. We reported previously that during <span class="Species">yeast cell senescence driven by telomere shortening, the telomeric protein Rap1 plays a major role in reprogramming gene expression by relocalizing hundreds of new target genes (called NRTS, for new Rap1 targets at senescence) to the promoters. This leads to two types of histone loss: Rap1 lowers histone level globally by repressing histone gene expression, and it also causes local nucleosome displacement at the promoters of upregulated NRTS. Here, we present evidence of direct binding between Rap1 and histone H3/H4 heterotetramers, and map amino acids involved in the interaction within the Rap1 SANT domain to amino acids 392-394 (SHY). Introduction of a point mutation within the native RAP1 locus that converts these residues to <span class="Chemical">alanines (<span class="Gene">RAP1SHY ), and thus disrupts Rap1-H3/H4 interaction, does not interfere with Rap1 relocalization to NRTS at senescence, but prevents full nucleosome displacement and gene upregulation, indicating direct Rap1-H3/H4 contacts are involved in nucleosome displacement. Consistent with this, the histone H3/H4 chaperone Asf1 is similarly unnecessary for Rap1 localization to NRTS but is required for full Rap1-mediated nucleosome displacement and gene activation. Remarkably, <span class="Gene">RAP1SHY does not affect the pace of senescence-related cell cycle <span class="Disease">arrest, indicating that some changes in gene expression at senescence are not coupled to this <span class="Disease">arrest.Entities:
Keywords: Rap1; cellular senescence; pace of senescence; pioneer transcription factor
Year: 2019 PMID: 31742863 PMCID: PMC6974733 DOI: 10.1111/acel.13061
Source DB: PubMed Journal: Aging Cell ISSN: 1474-9718 Impact factor: 9.304
Figure 1Rap1 binds histone H3/H4 tetramers. (a) Schematic of Rap1 fragments and domains, with amino acid positions indicated. (b) GST‐Rap1‐6X‐His protein was expressed in E. coli, purified using the His tag and then subjected to a GST pull‐down histone binding assay (300 mM NaCl; note that similar results were obtained up to at least 750 mM NaCl). Rap1 (0.5 μM) binds to H3/H4 tetramers (2 μM), but not H2A/H2B (2 μM) dimers. When H2A/H2B dimers and H3/H4 tetramers are mixed in 2:1 ratio as in the octameric histone core (4 μM H3/H4 and 2 μM H2A/H2B), Rap1 interacts specifically with H3/H4 tetramers. (c) Panels c–e use Rap1 protein purified using only the GST‐tag. GST pull‐down histone binding assay with truncated regions of Rap1 (400 mM NaCl) is shown. Rap1CΔ (0.5 μM) binds H3/H4 tetramers (2 μM) with similar strength as full‐length Rap1. Rap1N and Rap1C do not bind histones under these conditions. Note that when Rap1 constructs are not purified via a C‐terminal 6X‐His tag, proteins near the size of GST are detected, presumably due to translational termination or proteolytic degradation near the GST‐Rap1 junction. (d) GST pull‐down histone assay with equimolar Rap1 and histones (300 mM NaCl). Full‐length Rap1 (2 μM) and Rap1CΔ (2 μM) each binds H3/H4 (2 μM) robustly (~1:1). Rap1C (2 μM) displays detectable H3/H4 binding under these conditions. Similar interaction strengths are observed from salt concentrations ranging from 150 to 750 mM NaCl. (e) GST pull‐down histone binding assay with SANT domain (300 mM NaCl). Top panel: Coomassie stain of SANT domain (2 μM) interacting with H3/H4 (2 μM). Bottom panel: immunoblot against histone H3. (f) Quantitation of Rap1 fragments binding to H3/H4 under equimolar conditions. H3 signal is normalized to loading control, with full‐length wildtype Rap1 binding strength set as 1.0. Error bars indicate the standard error of the mean (N = 4)
Figure 2Amino acids 392–394 (SHY) facilitate Rap1‐histone interactions. (a) Location of alpha‐helices within the SANT domain, redrawn from Konig et al. (1996). Triple alanine mutants were generated from amino acids 359–410. (b) Immunoblot analysis of in vitro GST pull‐down assay of histones showing representative triple alanine mutants. Pull‐down was performed with equimolar GST‐SANT (0.5 μM) and histones (0.5 μM) at 400 mM NaCl. Bottom panel is the blot stained with Ponceau S as a loading control. (c) Quantitation of triple alanine mutants binding to H3/H4, normalized to Ponceau stain signal, and with WT SANT set to 1.0. Error bars for all quantitations indicate standard error of the mean (N = 2). Only mutant 12 (amino acids 392–394, SHY) showed a significant loss of H3 signal. (d) Two views of the SANT domain bound to DNA. Amino acids SHY side chains are colored in magenta. SHY is located immediately C‐terminal to helix 2, with side chains facing away from the Rap1‐DNA interaction surface. Image generated using Pymol (PDB ID: 3UKG). (e) Representative immunoblot analysis of GST pull‐down histone binding assay with full‐length Rap1 and Rap1SHY. Pull‐down was performed with 0.5 μM each Rap1 and H3/H4 at 400 mM NaCl. Rap1SHY displays a ~50% loss of histone binding. Bottom panel is a loading control gel stained with Coomassie blue. (f) Quantitation of full‐length Rap1 and Rap1SHY binding to H3/H4 (N = 3). (g) Representative immunoblot analysis of GST pull‐down histone assay using two truncated versions of Rap1 lacking the C‐terminus, Rap1CΔ and Rap1643 Δ. Pull‐down was performed with 2 μM Rap1 truncated constructs and 2 μM H3/H4 at 400 mM NaCl. Both truncated forms show a significant and similar loss of histone signal when amino acid SHY is mutated to AAA (rightmost two lanes). Bottom panel is Coomassie loading control. (h) Quantitation of g (N = 3). (i) Representative coimmunoprecipitation of histone H3 with immunoprecipitated HA‐Rap1 and HA‐Rap1SHY. Input is 5% of the WCE, and Rap1SHY shows a significant loss of histone binding in the extracts. (j) Quantitation of the ratio of co‐immunoprecipated H3 to input H3 signals in i (N = 3)
Figure 3Rap1SHY is deficient in NRTS activation and histone displacement. (a) Immunoblot analysis of TCA extracts of GAL1‐driven HA‐Rap1 and HA‐Rap1SHY accumulation after 130 min of induction with galactose, conditions also used for panels (b) and (c). (b) Rap1 levels at the promoters of the upregulated NRTS, measured by qPCR of ChIP samples from cells overexpressing HA‐Rap1 or HA‐Rap1SHY, and normalized to input. IgG is control immunoglobulin from nonimmunized rabbit, and MDP1 is a non‐Rap1 target. (c) Loss of H3 levels at the promoters of the upregulated NRTS. The fold H3 ChIP enrichment is the ratio of H3 levels at the promoters of the activated NRTS in induced versus uninduced cells, normalized to their levels at the promoter of the non‐Rap1 target gene MDP1 (p < .04). (d) Accumulation of HA‐Rap1 and HA‐Rap1SHY driven by the NOP1 promoter. (e) Accumulation of HA‐Rap1CΔ and HA‐Rap1CΔ,SHY driven by the NOP1 promoter. (f) mRNA levels of activated NRTS induced by Rap1 overexpression, measured by qPCR, and normalized to ACT1 and vector control. Rap1SHY and Rap1643Δ,SHY are similarly compromised in NRTS activation (p < .03). All error bars indicate the standard error of the mean
Figure 4Rap1SHY prevents upregulation of activated NRTS at senescence without affecting histone gene expression and the rate of senescence. (a) Rap1SHY does not alter the rate of senescence. Senescence assay of RAP1 (n = 3), RAP1 (n = 3), tlc1Δ RAP1 (n = 7), tlc1Δ RAP1 (n = 7) spore products. (b) Rap1SHY confers less NRTS activation at senescence. Relative expression of activated NRTS, measured by qPCR and normalized to nonsenescent strains (p < .05). (c) Histone gene repression is not affected by Rap1SHY. Relative histone gene expression was measured by qPCR and normalized to nonsenescent strains. All error bars indicate the standard error of the mean
Figure 5Asf1 is required for NRTS activation and histone displacement. (a) NRTS mRNA levels at senescence, measured by qPCR, and normalized to ACT1 and nonsenescent strains. asf1Δ tlc1Δ double mutants have reduced NRTS activation compared to tlc1Δ strains (N = 5, p < .025). (b) Asf1 is required for NRTS activation in response to NOP1‐driven Rap1 overexpression (Rap1 OE) (p < .02). (c) ChIP‐qPCR of Rap1 in WT and asf1Δ strains with Rap1 OE driven by GAL1. Rap1 localization to promoters of activated NRTS is not affected by ASF1 deletion (p values insignificant). ChIP signals are normalized to noninduced cells. (d) ChIP‐qPCR of histone H3 in WT and asf1Δ strains with Rap1 OE driven by GAL1. Histone displacement is diminished in asf1Δ strains (p < .05). ChIP signals are normalized to noninduced cells. (e) NRTS activation by Rap1 OE is blunted upon deletion of members of the HIR complex (p < .02). (f) asf1Δ does not affect the rate of senescence. Senescence assay with WT (n = 2), asf1Δ (n = 2), tlc1Δ (n = 5), and tlc1Δ asf1Δ (n = 5). (g) hir1Δ does not affect the rate of senescence. Senescence assay with WT (n = 2), hir1Δ (n = 2), tlc1Δ (n = 5), and tlc1Δ hir1Δ (n = 5). All error bars indicate the standard error of mean